Digital Pathology AI

Ibex Medical Analytics Vendor Risk Profile

Ibex Medical Analytics provides AI-powered digital pathology solutions designed to assist pathologists in cancer diagnostics, including prostate, breast, and gastric cancer detection.

Last verified: September 15, 2026Approved With RestrictionsElevated RiskYesHIPAA: Yes

Risk Score

/100

AI Trust

/100

Compliance Overview

HIPAA Compatible

Yes

BAA Available

Yes

Hosting Model

—

Healthcare Focused

Yes

Approval Status

Approved With Restrictions

Risk Level

Elevated Risk

Last Reviewed

2026-08-18

Last Verified

September 15, 2026

Review Frequency

Quarterly

Verification reflects VNDRIQ's latest automated source check. Editorial review is a separate human assessment.

AI & Data Policies

AI Training Policy

Uses medical images for development; requires strict adherence to privacy and regulatory standards.

Data Retention Policy

Compliant with medical record retention requirements and privacy regulations.

Support Access Risk

—

Approved Use Cases

Clinical decision support for pathologists in prostate cancer diagnosis using the FDA-cleared Ibex Prostate Detect software.

Restricted Use Cases

Only Ibex Prostate Detect is FDA-cleared; other solutions (breast, gastric) are Research Use Only (RUO) in the United States.

Deployment & Data Residency

Deployment Type

Cloud and On-Premise

Model Type

—

Deployment Environment

—

Hosting Regions

—

Available Regions

—

Data Residency

—

Customer Data Residency Options

—

Cross-Border Data Transfer

—

Data Residency Controls

—

Security & Compliance

SOC 2

Not explicitly stated, but maintains ISO 27001 and HITRUST

ISO 27001

Yes

ISO 42001

—

HIPAA Documentation

https://ibex-ai.com/trust-center

Encryption

Yes

SSO

Yes

MFA

Yes

Private Networking

—

Private Endpoints

—

Subprocessors

—

Incident Notifications

—

Security Whitepaper

—

Executive Summary

Primary Use Cases

Ibex Medical Analytics provides AI-powered digital pathology solutions designed to assist pathologists in cancer diagnosticsincluding prostatebreastand gastric cancer detection.

Major Strengths

HIPAA ReadinessCompliance Documentation

Key Procurement Considerations

TransparencyProduct MaturityCustomer Support InformationVendor-documented restrictions — verify applicability

Compliance Highlights

ISO 27001HIPAA claimed

Vendor Trust Score

Limited Trust Data

15

/100

HIPAA Readiness50
BAA Availability0*
Security Controls0*
Governance Documentation0*
Transparency0*
Product Maturity0*
Healthcare Focus33
Integration Readiness38
Customer Support Information0*
Compliance Documentation50

Informational framework based on publicly available and registry data. Not a certification or guarantee. Asterisks indicate categories with limited registry data.

Security & Compliance Dashboard

Standardized view of available registry security information. Not Verified indicates the registry has no documented data.

HIPAA StatusClaimed
BAA AvailabilityNot Verified
SOC 2Not Verified
ISO 27001Certified
HITRUSTCertified (HITRUST r2)
Encryption at RestNot Verified
Encryption in TransitNot Verified
Single Sign-On (SSO)Not Verified
Multi-Factor AuthNot Verified
Audit LoggingNot Verified
Role-Based AccessNot Verified
Data ResidencyNot Verified
Public Security DocsNot Verified
Incident ResponseNot Verified

AI Governance Maturity

Foundational9/100

Minimal governance documentation; early-stage controls.

Foundational
Developing
Established
Advanced
Leading

Assessed Indicators

Governance Documentation
Human Oversight
AI Policies
Compliance Transparency
Risk Management
Security Controls
Operational Governance

Procurement Risk Considerations

Informational considerations for procurement evaluation, not definitive ratings.

Governance Maturity

Foundational

Elevated Consideration

Security Readiness

0/100 security controls

Elevated Consideration

Compliance Readiness

50/100 compliance documentation

Moderate Consideration

Integration Complexity

API available — lower complexity

Low Consideration

Operational Complexity

Not Verified

Vendor Transparency

0/100 transparency

Elevated Consideration

Healthcare Experience

Healthcare focus not verified

Moderate Consideration

Documentation Completeness

0/100 governance docs

Elevated Consideration

Vendor Lifecycle & Change History

Available registry milestones. Detailed change tracking expands as the registry matures.

Profile Updated

2026-09-15

Last Website Review

2026-09-15

Last Verification

2026-09-15

Last Registry Review

2026-08-18

Registry Added

2026-08-18

Regulated Use Assessment

Healthcare

Healthcare Focused

Yes

HIPAA Compatibility

Yes

BAA Availability

Yes

Financial Services

SOC 2

Not explicitly stated, but maintains ISO 27001 and HITRUST

ISO 27001

Yes

VNDRIQ does not classify vendors as HIPAA Compliant, SEC Compliant, or FINRA Approved unless official evidence exists. Vendor suitability depends on each organization's governance requirements, contractual obligations, deployment model, risk tolerance, and applicable regulations.

Review Notes

FDA 510(k) clearance K241232 granted for Ibex Prostate Detect (formerly Galen Second Read) on January 24, 2025.

Quick Facts

Category

Digital Pathology AI

Headquarters

Tel Aviv, Israel

Year Founded

2016

Deployment Type

Cloud and On-Premise

Website

ibex-ai.com/
Verified

Risk Score

/100

AI Trust Score

/100

Last Reviewed

2026-08-18

Last Verified

September 15, 2026

Request Vendor Evaluation

Get a structured risk assessment and governance recommendation for Ibex Medical Analytics.

Vendor Governance

Approval Tier

Approved With Restrictions

BAA Verification

Not Started

PHI Exposure

High

AI Risk Level

High

Last Review

2026-09-15

Next Review Due

2026-11-18

Verification Status

Verified

Last Verified

2026-09-15

Next Review Date

2026-11-18

Review Frequency

Quarterly

Vendor Completeness Score

100/100

Complete

Website Present

+20

Category Assigned

+15

Approval Status Present

+15

BAA Status Present

+15

PHI Exposure Classified

+10

Risk Level Present

+10

Review Date Present

+10

Verification Notes Present

+5

Trust & Transparency

Last Reviewed Date

2026-08-18

Review Frequency

Quarterly

Vendor Verification Process

Every vendor is reviewed against public documentation, trust centers, and contract evidence before classification.

Editorial Independence Statement

VNDRIQ classifications are independent of vendor relationships. Ratings reflect available evidence and governance risk only.

Registry Update Policy

The registry is reviewed on a monthly cycle. All updates are editor-reviewed before publication; no automated public data changes.

Editorial Methodology

Vendors are evaluated across compliance, security, AI governance, and enterprise readiness. Each review follows a standardized 12-point checklist covering website, HIPAA, BAA, security, compliance, AI capabilities, deployment, pricing, product changes, ownership, integrations, and documentation.

Trust Signals

Editorial Review StatusPending Review
Last Reviewed2026-08-18
Last Updated2026-09-15
Verification Date2026-09-15
Registry ConfidenceNot Verified
Governance MaturityFoundational
Trust Score15/100
Compliance SnapshotHIPAA, ISO
Security SnapshotNot Verified

Vendor Benchmarking

Comparison against registry averages where supported. Benchmarks are informational and based on registry data.

Governance Maturity9 ↑ 4 vs avg 5
Security Readiness0 ↑ 0 vs avg 12
Documentation Completeness0 ↑ 0 vs avg 0
Integration Readiness38 ↑ 27 vs avg 11
Healthcare Specialization33 ↑ 18 vs avg 15
Compliance Transparency50 ↑ 42 vs avg 8
Overall Trust Score15 ↑ 6 vs avg 9
This vendorRegistry average

Ask VNDRIQ About This Vendor

Ask questions about Ibex Medical Analytics using registry data.

Ask VNDRIQ About Healthcare AI Vendors

Explore healthcare AI vendors, compare capabilities, identify documentation gaps, and understand procurement and governance considerations using information from the VNDRIQ registry.

Suggested prompts

VNDRIQ provides vendor intelligence and educational procurement support. Responses do not constitute legal, medical, cybersecurity, compliance, or procurement advice. Vendor information may be incomplete, vendor-reported, under review, or subject to change.

Do not enter patient information, PHI, passwords, or sensitive data.

VNDRIQ vendor ratings are for operational risk screening and governance support. Final approval should include legal, compliance, security, and contract review before any PHI or regulated data is shared. Risk classifications are based on available public information and internal review at time of last verification.